Abstract
One of the major concerns in treating malaria by conventional small drug molecules is the rapid emergence of drug resistance. Specific silencing of essential genes by antisense oliogomers has been proposed as an alternative approach that may result in antimalarial activity which is not associated with drug resistance. In addition, such an approach could be an important biological tool for studying many genes' function by reverse genetics. Here we present a novel methodology of using peptide nucleic acids (PNAs) as a useful tool for gene silencing in Plasmodium falciparum. PNAs, designed as specific antisense molecules, were conjugated to a cell penetrating peptide (CPP); namely, octa-D-lysine via the C-terminus, to allow facile delivery through cell membranes. PNAs added to P. falciparum cultures were found exclusively in infected erythrocytes and were eventually localized in nuclei of the parasites at all stages of intra erythrocytic development. We show that these PNAs specifically down regulated both a stably expressed transgene as well as an endogenous essential gene, which significantly reduced parasites' viability. This study paves the way for a simple approach to silence a variety of P. falciparum genes as means of deciphering their function and potentially to develop highly specific and potent antimalarial agents.
Original language | American English |
---|---|
Article number | e86802 |
Journal | PLoS ONE |
Volume | 9 |
Issue number | 1 |
DOIs | |
State | Published - 22 Jan 2014 |
Bibliographical note
Funding Information:RD is supported by the Israeli Academy for Science [660/09], the Abisch-Frenkel foundation and by the German Israeli Foundation [997/2008]. RD is also supported by the Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences. EY acknowledges the David R. Bloom Center for Pharmacy and the Grass Center for Drug Design and Synthesis of Novel Therapeutics for financial support. We thank Dr. Adva Biton for her technical support and Ms. Shiri Eshar for critically reading the manuscript.